Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.66%
#2 aelf aelf +23.60%
#3 Venom Venom +19.06%
#4 Decred Decred +11.55%
#5 Bitway Bitway +10.60%
#6 Pons Pons +10.32%
#7 Wibx Wibx +8.11%
#8 MarsCoin MarsCoin +7.93%
#9 Janction Janction +7.67%
#10 DexNet DexNet +7.56%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
設定
言語
日本
通貨
USD
テーマ
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics, Inc.

OTLC
株式のランク #30395
Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage... Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage biopharmaceutical company, specializes in developing therapeutics for rare oncological conditions. Its flagship therapeutic candidate, OT-101 – an antisense compound designed to inhibit TGF-ß2 – is currently undergoing Phase 3 clinical trials for both pancreatic cancer and glioblastoma. Beyond oncology, OT-101 is also being explored for its potential in treating various viral diseases, including severe acute respiratory syndrome (SARS) and coronaviruses. The company's pipeline further includes OXi4503, which is being advanced for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and CA4P, intended for the treatment of advanced metastatic melanoma.
株価
$0.03834
最終同期: 2026-08-18
時価総額
$17.01M
変化（1日）
-4.15%
変化（1年）
-24.82%
国
US
取引 Oncotelic Therapeutics, Inc. (OTLC)

カテゴリー

Healthcare
Oncotelic Therapeutics, Inc.（OTLC）の配当利回りの履歴
Oncotelic Therapeutics, Inc.（銘柄コード: OTLC）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Oncotelic Therapeutics, Inc.（OTLC）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE